Advertisement

Treatment of Atrial Fibrillation in Patients Affected by Sick Sinus Syndrome: Role of Prevention and Antitachycardia Pacing Algorithms. Preliminary Results from PITAGORA Study

  • M. Gulizia
  • S. Mangiameli
  • P. Gambino
  • V. Bulla
  • V. Spadola
  • G. Chiarandà
  • L. Vasquez
  • G. M. Francese
  • E. Chisari
  • A. Grammatico
Conference paper

Abstract

With a prevalence rising with age from 0.05% at age 25-35 years to more than 5% among people aged 69 years or more, atrial fibrillation (AF) and in general atrial tachyarrhythmias (AT) are now the single most common sustained arrhythmia [1]. Once considered a benign disease, AF is increasingly being recognized as a significant cause of morbidity and mortality. AT can be treated by a vast array of pharmaceutical and nonpharmacological therapies, suggest­ing that no single treatment is sufficiently simple, successful, and cheap to exclude other therapies. Many new therapies are presently being developed, among which are electrical therapies designed to prevent and convert AT. Clinical experience indicates that monotherapeutic approaches (drug, abla­tion, or device) are often associated with unsatisfactory results in the treat­ment of AT patients [1-12]. Because all therapies have poor efficacy when con­sidered alone, interest in the role of combinations of therapies (hybrid thera­py) has recently increased. The rationale underlying hybrid therapy is that a combination of modalities of intervention in AT might have a synergistic effect, with the efficacy of each intervention building upon that of the others [12]. At present this concept is being considered particularly in the prevention of AT recurrence, but hybrid therapy has also been utilized both in facilitating restoration to sinus rhythm and in control of heart rate.

Keywords

Atrial Fibrillation Implantable Cardioverter Defibrillator Sick Sinus Syndrome Atrial Tachyarrhythmia Civile Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Narayan SM, Cain ME, Smith JM (1997) Atrial fibrillation. Lancet 350:943–950PubMedCrossRefGoogle Scholar
  2. 2.
    Pritchett ELC, McCarthy EA, Wilkinson WE (1991) Propafenone treatment of symp­tomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-control­led, crossover trial in patients tolerating oral therapy. Ann Intern Med 114:539–544PubMedCrossRefGoogle Scholar
  3. 3.
    Coplen SE, Antman AM, Berlin JA, Hewitt P, Chaimers TC (1990) Efficacy and safety of quinidine therapy for mantenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 82:1106–1116PubMedCrossRefGoogle Scholar
  4. 4.
    Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG, on behalf of the Stroke Prevention in AF Investigators (1992) Antiarrhythmic drug therapy and cardiac mortality in AE J Am Coll Cardiol 20:527–532CrossRefGoogle Scholar
  5. 5.
    Cox JL, Canavan TE, Schuessler RB et al (1991) The surgical treatment of AF. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and AF. J Thorac Cardiovasc Surg 101: 408–426Google Scholar
  6. 6.
    Jais P, Haïssaguerre M, Shah DC et al (1997) A focal source of AF treated by discrete radiofrequency ablation. Circulation 95:572–576PubMedCrossRefGoogle Scholar
  7. 7.
    Haïssaguerre M, Jais P, Shah DC et al (1996) Right and left atrial radiofrequency catheter therapy of paroxysmal AF. J Cardiovasc Electrophysiol 12:1132–1144CrossRefGoogle Scholar
  8. 8.
    Ching Man K, Daoud E, Knight B et al (1996) Right atrial radiofrequency catheter ablation of paroxysmal AF. J Am Coll Cardiol 27:188A (Abstract)Google Scholar
  9. 9.
    Rosenqvist M, Brandt J, Schuller H (1988) Long-term pacing in sinus node disease: effect of stimulation mode on cardiovascular mortality and morbidity. Am Heart J 116:16–22PubMedCrossRefGoogle Scholar
  10. 10.
    Sgarbossa EB, Pinski SL, Maloney JD et al (1993) Chronic AF and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 88:1045–1053PubMedCrossRefGoogle Scholar
  11. 11.
    Jung W, Wolpert C, Esmailzadeh B et al (1998) Specific considerations with the auto­matic implantable atrial defibrillator. J Cardiovasc Electrophysiol 9(8 Suppl):S193–201PubMedCrossRefGoogle Scholar
  12. 12.
    Timmermans C, Levy S, Ayers GM et al (2000) Spontaneous episodes of atrial fibrilla­tion after implantation of the Metrix Atrioverter: observations on treated and non-treated episodes. Metrix Investigators. J Am Coll Cardiol 35(6):1428–1433PubMedCrossRefGoogle Scholar
  13. 13.
    Capucci A, Villani GQ (2000) Combined approach of pharmacological and non-phar­macological treatment of atrial fibrillation. In: Bloch-Thomsen PE, Clement DL.Everyday problems in cardiology. Excerpta Medica, Amsterdam, vol II, no 2, pp 3–8Google Scholar
  14. 14.
    Default P, Saksena S, Prakash A et al (1998) Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single-dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 32:1900–1908CrossRefGoogle Scholar
  15. 15.
    Saksena S, Prakash A, Michael H et al (1996) Prevention of recurrent AF with chronic dual-site right atrial pacing. J Am Coll Cardiol 28:687–694PubMedCrossRefGoogle Scholar
  16. 16.
    Vardas PE et al (1998) Low-dose amiodarone versus sotalol for suppression of recur­rent symptomatic AE Am .J Cardiol 81: 995–998CrossRefGoogle Scholar
  17. 17.
    Roy D, Talajic M, Dorian P et al (2000) Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913–920PubMedCrossRefGoogle Scholar
  18. 18.
    Ricci R, Santini M, Puglisi A et al (1999) Intermittent or continuous overdrive atrial pacing significantly reduces paroxysmal atrial fibrillation recurrences in brady-tachy syndrome. Pacing Cling Electrophysiol 22:A175 (abstract)Google Scholar
  19. 19.
    Barold S et al (1987) Implanted atrial pacemakers for paroxysmal atrial flutter. Ann Intern Med 107:144–149PubMedCrossRefGoogle Scholar
  20. 20.
    Connelly DT, de Belder MA, Cunningham D et al (1993) Long-term follow-up of patients treated with a software-based antitachycardia pacemaker. Br Heart J 69:250–254PubMedCrossRefGoogle Scholar
  21. 21.
    den Dulk K, Brugada P, Smeets J et al, (1990) Long-term antitachycardia pacing expe­rience for supraventricular tachycardia. Pacing Clin Electrophysiol 13:1020–1030CrossRefGoogle Scholar
  22. 22.
    den Dulk K et al (1983) A versatile pacemaker system for termination of tachycar­dias. Am J Card 52(7):731–738CrossRefGoogle Scholar
  23. 23.
    Fromer M, Gloor H, Kus T (1990) Clinical experience with the Intertach pulse genera­tor in patients with recurrent supraventricular and ventricular tachycardia. Pacing Clin Electrophysiol 13:1955–1959PubMedCrossRefGoogle Scholar
  24. 24.
    Kappenberger L, Valin H, Sowton E (1989) Multicenter long-term results of antitachy­cardia pacing for supraventricular tachycardias. Am J Cardiol 64:191–193PubMedCrossRefGoogle Scholar
  25. 25.
    McComb JM, Jameson S, Bexton R (1990) Atrial antitachycardia pacing in patients with supraventricular tachycardia: clinical experience with the Intertach pacemaker. Pacing Clin Electrophysiol 13:1948–1954PubMedCrossRefGoogle Scholar
  26. 26.
    Adler SW, Wolpert C, Warman EN et al (2001) Efficacy of pacing therapies for trea­ting atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104: 887–892PubMedCrossRefGoogle Scholar
  27. 27.
    Friedman PA, Dijkman B, Warman EN et al (2001) Atrial therapies reduce atrial arrhythamias burden in defibrillator patients. Circulation 104:1023–1028PubMedCrossRefGoogle Scholar
  28. 28.
    Disertori M, Padeletti L, Santini M et al (2001) Antitachycardia pacing therapies to terminate atrial tachycardia: the AT500 Italian Registry. Eur Heart J Suppl .3[Suppl. P]P16–P24CrossRefGoogle Scholar
  29. 29.
    Tsuji H, Fujiki A, Tani M et al (1992) Quantitative relationship between atrial refrac­toriness and the dispersion of refractoriness in atrial vulnerability. Pacing Clin Electrophysiol 15:403–410PubMedCrossRefGoogle Scholar
  30. 30.
    Gallagher MM, Camm AJ (1997) Classification of atrial fibrillation. Pacing Clin Electrophysiol 20:1603–1605PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • M. Gulizia
    • 1
  • S. Mangiameli
    • 2
  • P. Gambino
    • 3
  • V. Bulla
    • 4
  • V. Spadola
    • 5
  • G. Chiarandà
    • 6
  • L. Vasquez
    • 7
  • G. M. Francese
    • 1
  • E. Chisari
    • 8
  • A. Grammatico
    • 8
  1. 1.Cardiology DepartmentSan Luigi — S. Currò HospitalCatania
  2. 2.Cardiology DepartmentGaribaldi HospitalCatania
  3. 3.Cardiology DepartmentCivili HospitalSciacca
  4. 4.Cardiology DepartmentCannizzaro HospitalCatania
  5. 5.Cardiology DepartmentCivile HospitalRagusa
  6. 6.Cardiology DepartmentDi Maria HospitalSiracusa
  7. 7.Cardiology DepartmentCivile HospitalMilazzo
  8. 8.Medtronic ItalyRomeItaly

Personalised recommendations